2355 WESTWOOD BLVD. #139, LOS ANGELES, CA
Annual Meeting Results - Election of Directors at Kairos Pharma Ltd.
Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Annual Report to Security Holders
Investor Presentation
News, Material Contracts
Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
Changes in Board, Management or Compensation
To Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025
Q1
FY 2025
Q3
Q2
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
S-1
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
PRER14A
Definitive Information Statement
Preliminary Information Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
Definitive Revised Proxy Statement